Norland merges with European firm

Article

Bone densitometer manufacturer Norland has improved its internationalstatus. The Fort Atkinson, WI, company merged with Stratec Medizintechnik,an x-ray bone densitometer manufacturer based in Birkenfeld, Germany. The two companies have been

Bone densitometer manufacturer Norland has improved its internationalstatus. The Fort Atkinson, WI, company merged with Stratec Medizintechnik,an x-ray bone densitometer manufacturer based in Birkenfeld, Germany.

The two companies have been consolidated under Norland MedicalSystems, a Dutch holding company. Norland Medical Systems hasalso created Osteo Diagnostics to combine the international activitiesof Norland and Stratec.

Norland has pursued an aggressive growth strategy since catheterfirm Cordis sold the company to Novatech Management, an investmentgroup led by Albert S. Waxman, founder and former chairman ofDiasonics (SCAN 5/23/90 and 6/5/91). The chairman and CEO of NorlandMedical Systems is Reynald Bonmati, Waxman's partner in Novatech.

Norland Medical Systems will concentrate research efforts inBirkenfeld and will maintain manufacturing plants in Germany andWisconsin. The company has announced that it will focus on marketingStratec's peripheral quantitative CT system, the XCT-900. TheXCT-900 measures bone density in the wrist and will be marketedto pharmaceutical companies conducting osteoporosis drug research.

The new Norland is still privately owned, but intends to gopublic at some time in the future, according to Bonmati.

BRIEFLY NOTED:

  • Shareholders of Westmark International approved the spin-offof patient monitoring subsidiary SpaceLabs from ultrasound subsidiaryATL at the firm's annual meeting this month (SCAN 2/26/92).

Focusing purely on medical ultrasound, Westmark will take thename of its former subsidiary, Advanced Technology Laboratories,and start trading on the NASDAQ market on June 29 under the symbolATLI. SpaceLabs Medical will also trade on NASDAQ, beginning June17, under the symbol SLMD.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.